Background. This study evaluated the results of thoracic metastasectomy for
germ cell tumours to assess long term survival and identify prognostic fac
tors.
Patients and methods: A series of 141 consecutive patients who underwent re
section of thoracic metastases at Royal Brompton Hospital were retrospectiv
ely reviewed. Kaplan-Meier estimates of survival were calculated for clinic
al variables related to primary tumour and thoracic metastases, using the C
ox model for multivariate analysis.
Results: Complete resection was achieved in 123 cases (87%); pathology show
ed viable malignant elements in 46 (32%), necrosis or fibrosis in 32, diffe
rentiated teratoma in 63. The overall survival was 77% at five years and 65
% at 15 years, being significantly shorter in patients with malignant terat
omatous elements (51% at five years, P = 0.0001) or incomplete resection (6
4% at five years, P = 0.019). At multivariate analysis these factors retain
ed their prognostic value, with a relative risk of death of 5.7 for maligna
nt teratomatous elements and 4.0 for incomplete resection. In addition, the
Cox model revealed a 3.2 times higher risk of relapse in patients with mal
ignant teratomatuos elements at the time of thoracic metastasectomy.
Conclusions. These data confirm the value of thoracic metastasectomy to ass
es pathological response and achieve permanent cure of chemoresistant disea
se.